中國鐵建(01186.HK)聯營體簽署阿聯酋聯邦鐵路二期C0308合同段設計和施工合同
格隆匯12月18日丨中國鐵建(01186.HK)公告,近日,公司和阿聯酋國家工程和建設有限公司組成的聯營體與阿聯酋聯邦鐵路公司簽署阿聯酋聯邦鐵路二期C0308合同段設計和施工合同,聯營體中公司佔比為51%。項目工期1379天,線路總長為146.18公里,其中108.17公里為單線,38.01公里為雙線。合同金額約48.4743億阿聯酋迪拉姆,摺合人民幣約92.7046億元,其中本公司合同額約47.2793億元,約佔本公司中國會計準則下2018年營業收入的0.65%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.